Ticagrelor-Mepha 60 mg

Ticagrelor-Mepha 60 mg is a medicine authorised by Swissmedic under authorisation number 68827. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 December 2022 and the authorisation is limited until 20 December 2027. ATC code B01AC24 places the medicine in the group Antithrombotic agents.

  • Dispensing category B
  • Authorisation number 68827
  • ATC B01AC24
  • Synthetic medicines
Authorisation data
Authorisation number68827
NameTicagrelor-Mepha 60 mg
Full nameTicagrelor-Mepha 60 mg, Filmtabletten
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeB01AC24
First authorisation21 December 2022
Authorisation validity20 December 2027
Strengths
No.NameDispensing categoryAuthorisation date
1Ticagrelor-Mepha 60 mg, FilmtablettenB21 December 2022
2Ticagrelor-Mepha 90 mg, FilmtablettenB21 December 2022

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
156Tablette(n)B01AC2406.03.2.B
2168Tablette(n)B01AC2406.03.2.B
356Tablette(n)B01AC2406.03.2.B
5168Tablette(n)B01AC2406.03.2.B
698Tablette(n)B01AC2406.03.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Ticagrelor-Mepha 60 mg authorised in Switzerland?

Yes. Ticagrelor-Mepha 60 mg is authorised by Swissmedic under authorisation number 68827, data as of 01 September 2026. The authorisation is limited until 20 December 2027.

Which dispensing category does Ticagrelor-Mepha 60 mg have?

Ticagrelor-Mepha 60 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Ticagrelor-Mepha 60 mg?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com